These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


334 related items for PubMed ID: 12542474

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.
    Adekile A, Menzel S, Gupta R, Al-Sharida S, Farag A, Haider M, Akbulut N, Mustafa N, Thein SL.
    Am J Hematol; 2015 Jul; 90(7):E138-9. PubMed ID: 25851995
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hydroxurea and sickle cell disease: Its been a long, long time coming.
    Scott JP.
    Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298
    [No Abstract] [Full Text] [Related]

  • 6. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
    Lemonne N, Charlot K, Waltz X, Ballas SK, Lamarre Y, Lee K, Hierso R, Connes C, Etienne-Julan M, Romana M, Connes P.
    Haematologica; 2015 Oct; 100(10):e383-6. PubMed ID: 26137960
    [No Abstract] [Full Text] [Related]

  • 7. Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.
    Mvalo T, Topazian H, Kamthunzi P, Chen J, Kambalame I, Mafunga P, Mumba N, Chiume-Chiphaliwali M, Paseli K, Key N, Gopal S, Hoffman I, Ataga K, Westmoreland K.
    Blood Adv; 2018 Nov 30; 2(Suppl 1):30-32. PubMed ID: 30504195
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
    Obaro SK.
    Lancet Glob Health; 2015 Mar 30; 3(3):e124-5. PubMed ID: 25701988
    [No Abstract] [Full Text] [Related]

  • 10. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov 30; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 11. Update on the use of hydroxyurea therapy in sickle cell disease.
    Wong TE, Brandow AM, Lim W, Lottenberg R.
    Blood; 2014 Dec 18; 124(26):3850-7; quiz 4004. PubMed ID: 25287707
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hydroxycarbamide for sickle-cell anaemia in infancy.
    Weatherall DJ.
    Lancet; 2011 May 14; 377(9778):1628-30. PubMed ID: 21571132
    [No Abstract] [Full Text] [Related]

  • 15. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
    Nkashama GM, Wakamb GK, Mulangu AM, Nkashama GM, Kupa BK, Numbi OL.
    Pan Afr Med J; 2015 May 14; 21():124. PubMed ID: 26327961
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hydroxyurea for the treatment of sickle cell anemia.
    Platt OS.
    N Engl J Med; 2008 Mar 27; 358(13):1362-9. PubMed ID: 18367739
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
    Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, James AH, Laraque D, Mendez M, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M.
    Ann Intern Med; 2008 Jun 17; 148(12):932-8. PubMed ID: 18458271
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.